Hinge Health, Inc.·4

Mar 18, 5:18 PM ET

Sloat Tyler 4

4 · Hinge Health, Inc. · Filed Mar 18, 2026

Research Summary

AI-generated summary of this filing

Updated

Hinge Health Director Tyler Sloat Receives Award

What Happened

Tyler Sloat, a director of Hinge Health, Inc. (HNGE), was granted 9,896 restricted stock units (RSUs) on March 16, 2026. The Form 4 reports the acquisition as 9,896 shares at $0.00 (award/grant), meaning no cash changed hands at grant.

Key Details

  • Transaction date: 2026-03-16; Form 4 filed: 2026-03-18 (two days after the transaction date as reported).
  • Transaction type/code: Award/Grant (A).
  • Shares/units granted: 9,896 RSUs; reported acquisition price: $0.00; reported dollar value: $0.
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • Footnote: These are restricted stock units that vest according to the award terms; each RSU represents a contingent right to receive one share of Class A common stock (per Footnote F1).
  • No 10b5-1 plan, tax withholding, sale, or exercise activity is noted in this transaction.

Context

RSUs are a form of compensation that convert to actual shares only when they vest per the award schedule; they are not an immediate purchase or sale and do not necessarily indicate near-term buying or selling. This grant increases Sloat’s potential future ownership if and when the RSUs vest, but does not change outstanding shares until settlement.

Insider Transaction Report

Form 4
Period: 2026-03-16
Sloat Tyler
Director
Transactions
  • Award

    Class A Common Stock

    [F1]
    2026-03-16+9,8969,896 total
Footnotes (1)
  • [F1]Includes 9,896 restricted stock units that vest in accordance with the terms of the award. Each RSU represents a contingent right to receive one share of Class A Common Stock.
Signature
/s/ James Budge, Attorney-in-Fact|2026-03-18

Documents

1 file
  • 4
    form4-03182026_090312.xmlPrimary